Harvey Rubin
- Molecular Biology top 2%
- Infectious Diseases top 1%
- Epidemiology top 2%
- Genetics top 2%
- Cancer Research top 2%
- Co-authors
- David AvarbockBarry S. CoopermanNorman M. SchechterValerie MizrahiMichael BucksteinTakahiro YanoRichard H. TullisClifton E. Barry
- Topics
- Protease and Inhibitor Mechanisms (19 papers)Tuberculosis Research and Epidemiology (16 papers)RNA and protein synthesis mechanisms (13 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Harvey Rubin
120 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 150
- Molecular Biology 2.9k
- Infectious Diseases 1.5k
- Epidemiology 1.1k
- Genetics 829
- Cancer Research 724
Countries citing papers authored by Harvey Rubin
This map shows the geographic impact of Harvey Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey Rubin more than expected).
Fields of papers citing papers by Harvey Rubin
This network shows the impact of papers produced by Harvey Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey Rubin. The network helps show where Harvey Rubin may publish in the future.
Co-authorship network of co-authors of Harvey Rubin
This figure shows the co-authorship network connecting the top 25 collaborators of Harvey Rubin. A scholar is included among the top collaborators of Harvey Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey Rubin. Harvey Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 5 | |
| 4 | 97 | |
| 5 | 9 | |
| 6 | 9 | |
| 7 | 13 | |
| 8 | An enforceable international compact for infectious diseases: strategies to operationalize new initiatives to strengthen global health security. | 1 |
| 9 | 16 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 60 | |
| 13 | DNA based computers III : DIMACS Workshop, June 23-25, 1997 | 2 |
| 14 | 24 | |
| 15 | 89 | |
| 16 | 20 | |
| 17 | 50 | |
| 18 | 6 | |
| 19 | 49 | |
| 20 | 1 |
About Harvey Rubin
Harvey Rubin is a scholar working on Infectious Diseases, Cancer Research and Genetics, having authored 121 papers that have together received 5.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (19 papers), Tuberculosis Research and Epidemiology (16 papers) and RNA and protein synthesis mechanisms (13 papers). The work is most often cited by research in Molecular Medicine (551 citations), Infectious Diseases (1.5k citations) and Cancer Research (724 citations). Harvey Rubin has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include David Avarbock, Barry S. Cooperman, Norman M. Schechter, Valerie Mizrahi, Michael Buckstein, Takahiro Yano, Richard H. Tullis, Clifton E. Barry, J. S. Teh and Edward A. Weinstein. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.